CAS: 68238-36-8; Sodium 2-((4-(Diethylamino)Phenyl)(4-(Diethyliminio)Cyclohexa-2,5-Dien-1-Ylidene)Methyl)Benzene-1,4-Disulfonate

该化合物是淋巴图绘制手术过程中的合成染料;蓝色的可溶水染料,其颜色为蓝色,可清晰地看到淋巴容器;复合物的特征是能够与蛋白结合,有助于生物组织中本地化;蓝色的硫丹经常通过注射施用,其药理基因学涉及快速分布,最终通过尿道系统排出;染料一般是良好的,尽管有些病人可能经历过敏反应或其他副作用;除医疗用途外,蓝色的亚硫素还可以作为各种科学研究的追踪器;其稳定性和溶解性使它成为临床和研究环境中的宝贵工具,有助于其在医学领域的重要性.

结构式图片

欧盟法规

C&L通报

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-12180142-B1
    优先权日:2024-02-22
    标 题:Synthesis process for high purity isosulfan blue using flash chromatography in commercial plant scale
    发明人:KAVURU VIMAL; PATI KAMALKISHORE
    权利人:RISING PHARMA HOLDINGS INC
    摘要:A composition including a N-[4-[[4-(diethyl amino) phenyl](2,5-disulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-N-ethylethanaminium sodium salt, where the N-4-4-(diethylamino)phenyl (2,5-disulfophenyl)methylene-2,5-cyclohexadien-1-ylidene-N-ethylethanaminium sodium salt is at least 90% of the weight of such composition. A method of making the composition by a process including sulphonating 2-chlorobenzaldehyde, treatment with sodium sulphite and subsequent basification, a condensation step, an oxidation step and a purification step comprising utilizing HPLC to monitor the sulphonating step, the treatment step, the condensation step, and/or the oxidation step, to determine when one or more reactions of such sulphonating step, treatment step, condensation step, and/or oxidation step are substantially complete and ending such one or more reactions on the basis of the HPLC monitoring. The purification step utilizes flash chromatography to obtain a high purity N-[4-[[4-(diethyl amino) phenyl](2,5-disulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-N-ethylethanaminium sodium salt.

    专利号:US-6673940-B1
    优先权日:1999-01-08
    标 题:Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids
    发明人:DERVAN PETER B; BAIRD ELDON E
    权利人:CALIFORNIA INST OF TECHN
    摘要:The design, synthesis, and use of cyclic compounds, including cyclic polyamides, is described. Such compounds comprise at least two polymer portions, one of which comprises at least three molecular units, and the other comprises at least four molecular units. At least one molecular unit of such a compound is a hydrogen bond donor or acceptor. The polymer portions are covalently linked to form a cycle. These compounds are capable of targeting specific nucleotide sequences in double-stranded nucleic acids, particularly double-stranded DNA. Accordingly, such compounds can be used to modulate, e.g., increase or decrease, the expression of one or more genes in vitro or in vivo.

    专利号:EP-4361127-A2
    优先权日:2020-04-10
    标题 :Process for the synthesis of sulfonated triarylmethane compounds

    专利号:US-6984734-B2
    优先权日:2002-02-26
    标 题 :Cyclo[n]pyrroles and methods thereto
    发明人:SESSLER JONATHAN L; SEIDEL DANIEL; BOLZE FREDERIC R; KOEHLER THOMAS
    权利人:UNIV TEXAS
    摘要:The present invention provides an oxidative coupling procedure that allows efficient synthesis of novel cyclo[n]pyrrole macrocycles. Therefore, the present invention provides cyclo[n]pyrroles where n is 6, 7, 8, 9, 10, 11, or 12, and derivatives, multimers, isomers, and ion and neutral molecule complexes thereof as new compositions of matter. A protonated form of cyclo[n]pyrrole displays a gap of up to 700 nm between strong Soret and Q-like absorption bands in the electronic spectrum, demonstrating no significant ground state absorption in the visible portion of the electronic spectrum. Uses of cyclo[n]pyrroles as separation media, nonlinear optical materials, information storage media and infrared filters are provided.

    专利号:EP-1144414-B1
    优先权日:1999-01-08
    标 题 :Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids
    发明人:BAIRD ELDON E; DERVAN PETER B
    权利人:CALIFORNIA INST OF TECHN
    摘要:The design, synthesis, and use of cyclic compounds, including cyclic polyamides, is described. Such compounds comprise at least two polymer portions, one of which comprises at least three molecular units, and the other comprises at least four molecular units. At least one molecular unit of such a compound is a hydrogen bond donor or acceptor. The polymer portions are covalently linked to form a cycle. These compounds are capable of targeting specific nucleotide sequences in double-stranded nucleic acids, particularly double-stranded DNA. Accordingly, such compounds can be used to modulate, e.g., increase or decrease, the expression of one or more genes in vitro or in vivo.

    专利号:FR-3109150-A1
    优先权日:2020-04-10
    标题 :Process for the synthesis of sulfonated triarylmethane compounds
    浙江凯普化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.chempacific-china.com
    企业联系电话:0573-85576067;13586348435👤
    📞浙江凯普化工有限公司 ⚠️参考联系方式
    联系人:丘先生
    电话:0573-85576067;13586348435
    手机:13586348435
    传真:0573-85576068
    邮箱:pqiu@chempacific.com
    通信地址: 嘉兴港区乍浦开发区东方大道西侧
    邮编: 314201
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:嘉兴港区乍浦开发区东方大道西侧
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    北京翔宇恒天医药技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.eagleskypharmatech.com
    企业联系电话:010-88755821👤
    📞北京翔宇恒天医药技术有限公司 ⚠️参考联系方式
    联系人:李经理
    电话:010-88755821
    手机:13911359480

    邮箱:Contact@EagleSkyPharmatech.com
    通信地址: 北京市石景山区古城南街9号院6号楼
    邮编: 100039
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:北京市石景山区古城南街9号院6号楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Frumovitz M, Plante M, Lee PS, Sandadi S, Lilja JF, Escobar PF, Gien LT, Urbauer DL, Abu-Rustum NR. Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial. Lancet Oncol. 2018 Oct;19(10):1394-1403. doi: 10.1016/S1470-2045(18)30448-0. Epub 2018 Aug 22. doi: 10.1016/j.jvsv.2018.05.021. Epub 2018 Aug 17. doi: 10.5152/turkjsurg.2017.3137. eCollection 2018.
    4: Unkart JT, Proudfoot J, Wallace AM. Outcomes of "one-day" vs "two-day" injection protocols using Tc-99m tilmanocept for sentinel lymph node biopsy in breast cancer. Breast J. 2018 Jul;24(4):526-530. doi: 10.1111/tbj.13002. Epub 2018 Mar 2.
    5: Liberale G. Comments on 'Sentinel Lymph Node Mapping with Isosulfan Blue or Indocyanine Green in Colon Cancer Shows Comparable Results and Identifies Patients with Decreased Survival: A Prospective Single-Center Trial'. World J Surg. 2018 Nov;42(11):3816. doi: 10.1007/s00268-017-4457-x. doi: 10.1002/jso.24859. Epub 2017 Dec 11. doi: 10.1080/03639045.2017.1405428. Epub 2017 Dec 4. doi: 10.1002/micr.30222. Epub 2017 Aug 31. doi: 10.1007/s00432-017-2501-8. Epub 2017 Aug 21. Review. e1-10.e7. doi: 10.1016/j.jpurol.2017.06.017. Epub 2017 Jul 26. doi: 10.1097/IGC.0000000000001075. Review. doi: 10.1016/j.jacc.2017.04.023. doi: 10.1007/s00268-017-4051-2. doi: 10.1097/IGC.0000000000000959.

    合成参考文献


    参考文献:10.1007/s00595-010-4528-1
    摘要:Nomori H, Kohno M, Izumi Y, Ohtsuka T, Asakura K, Nakayama T. Sentinel nodes in lung cancer: review of our 10-year experience. Surg Today. 2011 Jul;41(7):889–95. doi: 10.1007/s00595-010-4528-1.
    参考文献:10.1186/1477-7819-9-80
    摘要:Kwon S, Dong ZM, Wu PC. Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma: clinical experience and review of literature. World Journal of Surgical Oncology. 2011 Jul 19;9(1):80. doi: 10.1186/1477-7819-9-80.
    参考文献:10.1007/s10549-005-9007-9
    摘要:Ozmen V, Karanlik H, Cabioglu N, Igci A, Kecer M, Asoglu O, Tuzlali S, Mudun A. Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer. Breast Cancer Research and Treatment. 2005 Dec 02;95(1):1–6. doi: 10.1007/s10549-005-9007-9.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知